Project Grant F32HD112151

Award Date 11/1/24
Completion Date 10/31/27
Dollars Obligated $172K
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
New York, NY 10065, USA
Similar Awards
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $1,831,848 to the University of Rochester to investigate how neonatal microbiome colonization impacts lung immunity and regeneration. The research aims to elucidate how early-life microbial dysbiosis remodels the developmental program in lung-resident lymphocytes and epithelial cells, contributing to chronic respiratory disease. Key...
This Project Grant award of $565,834 from the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (CFDA 93.837 Cardiovascular Diseases Research), aims to investigate the long-term impact of early-life respiratory syncytial virus (RSV) infection on the development of childhood asthma. The research will focus on understanding how RSV infection can cause epigenetic modifications in lung epithelial cells that lead to persistent changes in the lung's...
The Regents of the University of California at Riverside received a $741,522 Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The award will fund a 3-year research project titled "Identifying Inter-Kingdom Microbial Determinants of Altered Immunity in HIV Exposed Infants." The project aims to longitudinally investigate interactions between the gut virome,...
This federal Project Grant award of $508,500.00 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports a study titled "BREATH - Breastfeeding, Early-Life Microbiome and Respiratory Health Study" at New York University School of Medicine. The research aims to elucidate the intricate relationships between breastfeeding, infant microbiome development, and early-life respiratory health...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $816,358 to Vanderbilt University Medical Center (VUMC) to conduct research on the effects of infant antibiotic exposure on the development of the early-life airway and gut microbiome, and the associated risk of childhood asthma. The goals of this 5-year project are to: 1) determine the age when infants are most susceptible to the harmful...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) provides $412,500.00 in funding to the University of South Florida (USF) to conduct a longitudinal study of gut dysbiosis in anemic preterm infants. The goal is to determine the hematocrit threshold associated with gut microbiome changes and how anemia development influences the microbiome and host interactions...
This Project Grant award of $597,904, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support a comprehensive analysis of the impact of the infant microbiome and its interactions with host genetics on childhood asthma risk. The researchers at the University of Wisconsin-Madison will develop novel statistical methods to: (1) detect associations between the infant microbiome and host...
This Project Grant award of $2,024,790 from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), supports research to develop a novel probiotic therapy for preventing and treating neurodevelopmental impairment (NI) in premature infants. The central goal is to optimize the antimicrobial and anti-inflammatory properties of the probiotic Limosilactobacillus reuteri (LR) delivered via a...
The National Institute of Child Health and Human Development (NICHD) awarded a $463,360 Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to Weill Medical College of Cornell University for a project titled "Maternal Milk Cytokines Activate Cognate Receptors in the Neonatal Esophagus to Program Adult Social Behavior." The research aims to determine how maternal milk cytokines interact with receptors in the neonatal esophagus to influence brain...
This Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under the federal Child Health and Human Development Extramural Research program (CFDA 93.865), provides $1,376,850 to conduct research on interventions to protect HIV-exposed uninfected (HEU) infants against severe infections. The research aims to: Define immunogenomic and metabolomic profiles that explain HEU immune dysfunctions; Compare gut and respiratory microbiome...

The National Institute of Child Health and Human Development (NICHD) awarded a $171,728 Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to Weill Medical College of Cornell University to study the role of premature infant gut microbiome dysbiosis in mediating immune development and response to respiratory syncytial virus (RSV) infection. The research aims to define how the altered gut microbiome in premature infants impacts their ability to mount effective immune responses to RSV, which could contribute to more severe lung injury and increased asthma risk later in life. The project will identify potential metabolites that could help "normalize" respiratory immune responses and improve lung function in premature infants with RSV infection. The award has an ultimate completion date of October 31, 2027.

Generated 7/1/25, 2:47 AM